229 related articles for article (PubMed ID: 28061374)
21. Different genomic and metabolic patterns between mass screening-positive and mass screening-negative later-presenting neuroblastomas.
Nakagawara A; Zaizen Y; Ikeda K; Suita S; Ohgami H; Nagahara N; Sera Y; Akiyama H; Kawakami K; Uchino J
Cancer; 1991 Nov; 68(9):2037-44. PubMed ID: 1913552
[TBL] [Abstract][Full Text] [Related]
22. Urine catecholamine levels as diagnostic markers for neuroblastoma in a defined population: implications for ophthalmic practice.
Smith SJ; Diehl NN; Smith BD; Mohney BG
Eye (Lond); 2010 Dec; 24(12):1792-6. PubMed ID: 20865029
[TBL] [Abstract][Full Text] [Related]
23. Urinary VMA, dopamine and the likelihood of neuroblastoma: a preferred way of reporting laboratory results?
Sies CW; Florkowski CM; Sullivan M; Mackay R; George PM
Ann Clin Biochem; 2006 Jul; 43(Pt 4):300-5. PubMed ID: 16824281
[TBL] [Abstract][Full Text] [Related]
24. Quantitation of Neuroblastoma Markers Homovanillic Acid (HVA) and Vanillylmandelic Acid (VMA) in Urine by Gas Chromatography-Mass Spectrometry (GC/MS).
Beals M; Ramoo B; Clinton Frazee C; Garg U
Methods Mol Biol; 2022; 2546():185-194. PubMed ID: 36127589
[TBL] [Abstract][Full Text] [Related]
25. Tumour markers are poor predictors for relapse or progression in neuroblastoma.
Simon T; Hero B; Hunneman DH; Berthold F
Eur J Cancer; 2003 Sep; 39(13):1899-903. PubMed ID: 12932669
[TBL] [Abstract][Full Text] [Related]
26. Catecholamine metabolites in ganglioneuroma.
Lucas K; Gula MJ; Knisely AS; Virgi MA; Wollman M; Blatt J
Med Pediatr Oncol; 1994; 22(4):240-3. PubMed ID: 8107654
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of plasma 3,4-dihydroxyphenylacetic acid (DOPAC) and plasma 3,4-dihydroxyphenylalanine (DOPA) as tumor markers in children with neuroblastoma.
Eldrup E; Clausen N; Scherling B; Schmiegelow K
Scand J Clin Lab Invest; 2001; 61(6):479-90. PubMed ID: 11681538
[TBL] [Abstract][Full Text] [Related]
28. Serum vanillylmandelic acid/homovanillic acid contributes to prognosis estimation in patients with localised but not with metastatic neuroblastoma.
Berthold F; Hunneman DH; Harms D; Käser H; Zieschang J
Eur J Cancer; 1992; 28A(12):1950-4. PubMed ID: 1419287
[TBL] [Abstract][Full Text] [Related]
29. [Biochemical diagnosis of pheochromocytoma and neuroblastomas].
Candito M; Billaud E; Chauffert M; Cottet-Emard JM; Desmoulin D; Garnier JP; Greffe J; Hirth C; Jacob N; Millot F; Nignan A; Patricot MC; Peyrin L; Plouin PF
Ann Biol Clin (Paris); 2002; 60(1):15-36. PubMed ID: 11830391
[TBL] [Abstract][Full Text] [Related]
30. Effect of diet on urinary excretion of VMA, HVA, metanephrine, and total free catecholamine in normal preschool children.
Weetman RM; Rider PS; Oei TO; Hempel JS; Baehner RL
J Pediatr; 1976 Jan; 88(1):46-50. PubMed ID: 1245941
[TBL] [Abstract][Full Text] [Related]
31. Preanalytical validation and reference values for a mass spectrometric assay of serum vanillylmandelic acid for screening of catecholamine secreting neuroendocrine tumors.
Tohmola N; Itkonen O; Turpeinen U; Joenväärä S; Renkonen R; Hämäläinen E
Clin Chim Acta; 2015 Jun; 446():206-12. PubMed ID: 25896957
[TBL] [Abstract][Full Text] [Related]
32. Conjugated versus "free" acidic metabolites of catecholamines in random urine samples: significance for the diagnosis of neuroblastoma.
Tuchman M; Stoeckeler JS
Pediatr Res; 1988 Jun; 23(6):576-9. PubMed ID: 3393388
[TBL] [Abstract][Full Text] [Related]
33. Plasma levels of free metanephrines and 3-methoxytyramine indicate a higher number of biochemically active HNPGL than 24-h urinary excretion rates of catecholamines and metabolites.
van Duinen N; Corssmit EP; de Jong WH; Brookman D; Kema IP; Romijn JA
Eur J Endocrinol; 2013 Sep; 169(3):377-82. PubMed ID: 23832865
[TBL] [Abstract][Full Text] [Related]
34. Comparative values of catecholamines and metabolites for the diagnosis of neuroblastoma.
Monsaingeon M; Perel Y; Simonnet G; Corcuff JB
Eur J Pediatr; 2003 Jun; 162(6):397-402. PubMed ID: 12684897
[TBL] [Abstract][Full Text] [Related]
35. Determination of homovanillic acid and vanillylmandelic acid in neuroblastoma screening by stable isotope dilution GC-MS.
Fauler G; Leis HJ; Huber E; Schellauf C; Kerbl R; Urban C; Gleispach H
J Mass Spectrom; 1997 May; 32(5):507-14. PubMed ID: 9180052
[TBL] [Abstract][Full Text] [Related]
36. Catecholamine metabolism in neuroblastoma.
LaBrosse EH; Comoy E; Bohuon C; Zucker JM; Schweisguth O
J Natl Cancer Inst; 1976 Sep; 57(3):633-8. PubMed ID: 10450
[TBL] [Abstract][Full Text] [Related]
37. Increased urinary HVA levels in neuroblastoma screens related to diet, not tumor.
Numata K; Kusui H; Kawakatsu H; Kizaki Z; Sawada T
Pediatr Hematol Oncol; 1997; 14(6):569-76. PubMed ID: 9383810
[TBL] [Abstract][Full Text] [Related]
38. Clinical usefulness of iodine-123-MIBG scintigraphy for patients with neuroblastoma detected by a mass screening survey.
Hashimoto T; Koizumi K; Nishina T; Abe K
Ann Nucl Med; 2003 Dec; 17(8):633-40. PubMed ID: 14971604
[TBL] [Abstract][Full Text] [Related]
39. New semi-quantitative 123I-MIBG estimation method compared with scoring system in follow-up of advanced neuroblastoma: utility of total MIBG retention ratio versus scoring method.
Sano Y; Okuyama C; Iehara T; Matsushima S; Yamada K; Hosoi H; Nishimura T
Ann Nucl Med; 2012 Jul; 26(6):462-70. PubMed ID: 22528971
[TBL] [Abstract][Full Text] [Related]
40. Interchangeability between 24-hour collection and single spot urines for vanillylmandelic and homovanillic acid levels in the diagnosis of neuroblastoma.
Cangemi G; Barco S; Reggiardo G; Viscardi E; Di Cataldo A; Garaventa A; Melioli G; Conte M
Pediatr Blood Cancer; 2013 Dec; 60(12):E170-2. PubMed ID: 23813598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
